Is cardiovascular comorbidity the cause of elevated C-reactive protein in Covid-19 positive patients?

Introduction: recent epidemiological studies in China have reported an increased risk for the patient with heart comorbidities in patients with the coronavirus 19. Objectives: to determine the degree of association between the reported cardiovascular morbidity and the elevation of C-reactive protein...

Full description

Saved in:
Bibliographic Details
Published inActa médica del Centro : revista del Hospital Clínico Quirúrgico "Arnaldo Milián Castro" Vol. 14; no. 3; pp. 304 - 312
Main Author Guillermo Alberto Pérez Fernández
Format Journal Article
LanguageSpanish
Published Editorial Ciencias Médicas 01.07.2020
Subjects
comorbilidad cardiovascular
covid-19
proteína c reactiva
sars‐cov-2
Online AccessGet full text

Cover

More Information
Summary:Introduction: recent epidemiological studies in China have reported an increased risk for the patient with heart comorbidities in patients with the coronavirus 19. Objectives: to determine the degree of association between the reported cardiovascular morbidity and the elevation of C-reactive protein in patients positive for the coronavirus 19. Methods: a cross-sectional descriptive study was carried out on a sample of 52 patients diagnosed with coronavirus 19 and hospitalized in the “Celestino Hernández Robau” Hospital in Santa Clara city, Villa Clara, Cuba which was dedicated exclusively to the care of this type of patient during the pandemic. Two groups were formed based on the presence of cardiovascular comorbidity. Results: among the associated comorbidities, arterial hypertension predominated (32.7%), there were no significant differences between the proportion of individuals with a high or normal C-reactive protein, regardless of the group they were in (p=0.79). Conclusions: there was no important association between cardiovascular morbidity and C-reactive protein elevation in coronavirus-positive patients 19.
ISSN:2709-7927